Yalcintepe, L. Et Al. 2020. Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells. Clinical and Experimental Pharmacology and Physiology , vol.47, no.7 , 1221-1230.

Yalcintepe, L., Erdag, D., AKBAŞ, F., & Kucukkaya, B., (2020). Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells. Clinical and Experimental Pharmacology and Physiology , vol.47, no.7, 1221-1230.

Yalcintepe, Leman Et Al. "Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells," Clinical and Experimental Pharmacology and Physiology , vol.47, no.7, 1221-1230, 2020

Yalcintepe, Leman Et Al. "Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells." Clinical and Experimental Pharmacology and Physiology , vol.47, no.7, pp.1221-1230, 2020

Yalcintepe, L. Et Al. (2020) . "Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells." Clinical and Experimental Pharmacology and Physiology , vol.47, no.7, pp.1221-1230.

@article{article, author={Leman Yalcintepe Et Al. }, title={Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells}, journal={Clinical and Experimental Pharmacology and Physiology}, year=2020, pages={1221-1230} }